AnalystsBrandon FolkesBrandon Folkes's Stock Forecasts
AnalystsBrandon Folkes
Analyst Ranking
Bottom 7%
#4578 out of 4870 analysts
Average Return
-21.11%
Win Rate
22%10 out of 46
Risk vs Reward
Poor
Good
Brandon Folkes's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Trevi Therapeutics IncTRVI | +149.10% | $2.77 | $6.90 | 2024-06-12 - 2025-05-01 | Strong Buy |
Elutia IncELUT | +130.77% | $1.43 | $3.30 | 2023-08-14 - 2024-08-14 | Strong Buy |
Cormedix IncCRMD | +53.91% | $6.27 | $9.65 | 2024-08-25 - 2025-05-01 | Strong Buy |
Elutia IncELUT | +41.81% | $2.32 | $3.29 | 2023-05-11 - 2024-05-10 | Strong Buy |
Eupraxia Pharmaceuticals IncEPRX | +33.10% | $2.90 | $3.86 | 2024-11-13 - 2025-05-01 | Strong Buy |
Brandon Folkes Analyst Color
Get additional color on Brandon Folkes's coverage of popular stocks
Brandon Folkes's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rockwell Medical IncRMTI | 1 | Strong Buy | $5.00 | +362.96% | Initiates Coverage On | 6 months ago |
Achieve Life Sciences IncACHV | 1 | Strong Buy | $12.00 | +389.80% | Initiates Coverage On | 6 months ago |
Eupraxia Pharmaceuticals IncEPRX | 1 | Strong Buy | $9.00 | +133.16% | Initiates Coverage On | 6 months ago |
Omeros CorpOMER | 1 | Strong Buy | $9.00 | +28.21% | Initiates Coverage On | 6 months ago |
Adial Pharmaceuticals IncADIL | 1 | Strong Buy | $8.00 | +925.64% | Initiates Coverage On | 6 months ago |
Emergent Biosolutions IncEBS | 4 | Strong Buy | $16.00 | +225.20% | Reiterates | 8 months ago |
Cormedix IncCRMD | 1 | Strong Buy | $13.00 | +34.72% | Initiates Coverage On | 8 months ago |
Milestone Pharmaceuticals IncMIST | 1 | Strong Buy | $9.00 | +581.82% | Initiates Coverage On | 8 months ago |
Mannkind CorpMNKD | 1 | Strong Buy | $8.00 | +61.62% | Initiates Coverage On | a year ago |
Trevi Therapeutics IncTRVI | 1 | Strong Buy | $7.00 | +1.45% | Initiates Coverage On | a year ago |
Heron Therapeutics IncHRTX | 1 | Strong Buy | $7.00 | +197.87% | Initiates Coverage On | a year ago |
Rani Therapeutics Holdings IncRANI | 2 | Strong Buy | $10.00 | +834.58% | Initiates Coverage On | a year ago |
Scilex Holding CoSCLX | 1 | Strong Buy | $455.00 | +8,821.57% | Initiates Coverage On | a year ago |
Sanara Medtech IncSMTI | 4 | Strong Buy | $59.00 | N/A | Reiterates | 2 years ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $180.00 | N/A | Reiterates | 2 years ago |
Elutia IncELUT | 3 | Strong Buy | $8.00 | N/A | Reiterates | 2 years ago |
Amryt Pharma PLCAMYT | 2 | Hold | $14.75 | N/A | Downgrades | 2 years ago |
Veru IncVERU | 2 | Strong Buy | $22.00 | N/A | Maintains | 2 years ago |
Sorrento Therapeutics IncSRNEQ | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | 3 years ago |
Obseva SaOBSVF | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Journey Medical CorpDERM | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Alkermes PLCALKS | 1 | Strong Buy | $32.00 | N/A | Upgrades | 3 years ago |
IMV IncIMVIQ | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Redhill Biopharma LtdRDHL | 1 | Strong Buy | $22,000.00 | N/A | Initiates Coverage On | 4 years ago |
Collegium Pharmaceutical IncCOLL | 3 | Hold | $22.00 | N/A | Downgrades | 4 years ago |
Polypid LtdPYPD | 1 | Strong Buy | $720.00 | N/A | Initiates Coverage On | 4 years ago |
Trevena IncTRVN | 1 | Strong Buy | $3,125.00 | N/A | Initiates Coverage On | 5 years ago |
Ani Pharmaceuticals IncANIP | 2 | Hold | $40.00 | N/A | Downgrades | 5 years ago |
Optinose IncOPTN | 3 | Strong Buy | $315.00 | N/A | Reiterates | 5 years ago |
Eagle Pharmaceuticals IncEGRX | 2 | Hold | $46.00 | N/A | Maintains | 5 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $30.00 | N/A | Reiterates | 5 years ago |
Opiant Pharmaceuticals IncOPNT | 1 | Strong Buy | $42.00 | N/A | Maintains | 7 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Strong Buy | $50.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.